Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage Small Cell Lung Cancer: Results From TROPiCS-03.
Dowlati A, Chiang AC, Cervantes A, Babu S, Hamilton E, Wong SF, Tazbirkova A, Sullivan IG, van Marcke C, Italiano A, Patel J, Mekan S, Wu T, Waqar SN. Dowlati A, et al. J Thorac Oncol. 2025 Jan 2:S1556-0864(24)02549-8. doi: 10.1016/j.jtho.2024.12.028. Online ahead of print. J Thorac Oncol. 2025. PMID: 39755168
Assessment of targets of antibody drug conjugates in SCLC.
Ajay A, Wang H, Rezvani A, Savari O, Grubb BJ, McColl KS, Yoon S, Joseph PL, Kopp SR, Kresak AM, Peacock CD, Wildey GM, Lam M, Miyagi M, Kao HY, Dowlati A. Ajay A, et al. Among authors: dowlati a. NPJ Precis Oncol. 2025 Jan 2;9(1):1. doi: 10.1038/s41698-024-00784-7. NPJ Precis Oncol. 2025. PMID: 39748112 Free PMC article.
Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer.
Ireland AS, Hawgood SB, Xie DA, Barbier MW, Lucas-Randolph S, Tyson DR, Zuo LY, Witt BL, Govindan R, Dowlati A, Moser JC, Puri S, Rudin CM, Chan JM, Elliott A, Oliver TG. Ireland AS, et al. Among authors: dowlati a. bioRxiv [Preprint]. 2024 Nov 15:2024.11.13.623500. doi: 10.1101/2024.11.13.623500. bioRxiv. 2024. PMID: 39605338 Free PMC article. Preprint.
First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced Malignancies.
Lakhani NJ, Papadopoulos KP, Johnson ML, Park H, Wang D, Yap TA, Dowlati A, Maki RG, Ulahannan S, Lynce F, Kelly K, Williamson S, Malhotra J, Chen S, Gonzalez Ortiz A, Jankovic V, Paccaly A, Masinde S, Mani J, Lowy I, Gullo G, Sims T, Kroog G. Lakhani NJ, et al. Among authors: dowlati a. Clin Cancer Res. 2024 Dec 16;30(24):5601-5611. doi: 10.1158/1078-0432.CCR-23-3883. Clin Cancer Res. 2024. PMID: 39422598 Free PMC article. Clinical Trial.
Reply to P. de Boissieu et al.
Spigel DR, Dowlati A, Chen Y, Navarro A, Chih-Hsin Yang J, Stojanovic G, Jove M, Rich P, Andric ZG, Wu YL, Rudin CM, Chen H, Zhang L, Yeung S, Benzaghou F, Paz-Ares L, Bunn PA. Spigel DR, et al. Among authors: dowlati a. J Clin Oncol. 2024 Oct 9:JCO2401374. doi: 10.1200/JCO-24-01374. Online ahead of print. J Clin Oncol. 2024. PMID: 39383484 No abstract available.
Identification of HEPACAM2 as a novel and specific marker of small cell carcinoma.
McColl KS, Ajay A, Wang H, Wildey GM, Yoon S, Grubb B, Kopp SR, Joseph PL, Saviana M, Romano G, Nana-Sinkam P, Peacock CD, Yun Z, Mneimneh W, Lam M, Miyagi M, Kao HY, Dowlati A. McColl KS, et al. Among authors: dowlati a. Cancer. 2025 Jan 1;131(1):e35557. doi: 10.1002/cncr.35557. Epub 2024 Sep 20. Cancer. 2025. PMID: 39301750 Free PMC article.
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer.
Morgensztern D, Ready N, Johnson ML, Dowlati A, Choudhury N, Carbone DP, Schaefer E, Arnold SM, Puri S, Piotrowska Z, Hegde A, Chiang AC, Iams W, Tolcher A, Nosaki K, Kozuki T, Li T, Santana-Davila R, Akamatsu H, Murakami H, Yokouchi H, Wang S, Zha J, Li R, Robinson RR, Hingorani P, Jeng EE, Furqan M. Morgensztern D, et al. Among authors: dowlati a. Clin Cancer Res. 2024 Nov 15;30(22):5042-5052. doi: 10.1158/1078-0432.CCR-24-1547. Clin Cancer Res. 2024. PMID: 39287821 Free PMC article. Clinical Trial.
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update.
Dowlati A, Hummel HD, Champiat S, Olmedo ME, Boyer M, He K, Steeghs N, Izumi H, Johnson ML, Yoshida T, Bouchaab H, Borghaei H, Felip E, Jost PJ, Gadgeel S, Chen X, Yu Y, Martinez P, Parkes A, Paz-Ares L. Dowlati A, et al. J Clin Oncol. 2024 Oct 10;42(29):3392-3399. doi: 10.1200/JCO.24.00553. Epub 2024 Aug 29. J Clin Oncol. 2024. PMID: 39208379 Free PMC article. Clinical Trial.
A Pilot Trial of Proton-Based Cardiac Sparing Accelerated Fractionated Radiation Therapy in Unresectable Non-small Cell Lung Cancer With Extended Durvalumab Therapy (PARTICLE-D).
Bruno DS, Mitchell C, Dowlati A, Shamp S, Fu P, Rindeau J, Zheng Y, Machtay M, Biswas T. Bruno DS, et al. Among authors: dowlati a. Pract Radiat Oncol. 2024 Nov-Dec;14(6):e470-e479. doi: 10.1016/j.prro.2024.06.007. Epub 2024 Jul 14. Pract Radiat Oncol. 2024. PMID: 39002856 Clinical Trial.
E-Cigarette Use and Lung Cancer Screening Uptake.
Wang Q, Jiang C, Hsu ML, Wisnivesky J, Dowlati A, Boffetta P, Kong CY. Wang Q, et al. Among authors: dowlati a. JAMA Netw Open. 2024 Jul 1;7(7):e2419648. doi: 10.1001/jamanetworkopen.2024.19648. JAMA Netw Open. 2024. PMID: 38954419 Free PMC article.
253 results